NAGIOS: RODERIC FUNCIONANDO

Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents

Mostra el registre parcial de l'element

dc.contributor.author Rodríguez Lozano, Francisco Javier es
dc.contributor.author Oñate Sánchez, Ricardo Elías es
dc.date.accessioned 2017-07-21T07:52:08Z
dc.date.available 2017-07-21T07:52:08Z
dc.date.issued 2016 es
dc.identifier.citation Rodríguez Lozano, Francisco Javier ; Oñate Sánchez, Ricardo Elías. Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents. En: Medicina oral, patología oral y cirugía bucal. Ed. inglesa, 21 5 2016: 15- es
dc.identifier.uri http://hdl.handle.net/10550/59761
dc.description.abstract The clinical management of medication-related osteonecrosis of the jaw (MRONJ) in patients treated with bisphosphonates and other antiresorptive agents is subject to controversy. The American Association of Oral and Maxillofacial Surgeons (AAOMS) has developed guidelines for the correct management of the disorder which are revised and updated by a panel of experts. The present systematic review analyzes the different treatments currently used to treat this clinical condition, based on the PRISMA® (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement published in 2009. An electronic Medline search was made of the PubMed database, covering the period 2006-2014. The last search date was 31 December 2014. A total of 29 articles were selected from the initial search according to the different drugs implicated in the appearance of osteonecrosis; the treatment modality used according to the stage of the disease; and the recorded success rate. It is currently still recommended that the management of MRONJ should be decided according to the stage of the disease ? conservative treatment being preferred in early stages without symptoms, while surgical management is preferred in the case of bone exposure with symptoms. es
dc.title Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents es
dc.type journal article es_ES
dc.subject.unesco UNESCO::CIENCIAS MÉDICAS es
dc.identifier.doi 10.4317/medoral.20980 es
dc.type.hasVersion VoR es_ES

Visualització       (578.2Kb)

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a RODERIC

Cerca avançada

Visualitza

Estadístiques